{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-25-068190","form_type":"8-K","ticker":"INM","cik":"0001728328","company_name":"InMed Pharmaceuticals Inc.","filed_at":"2025-07-28T23:59:59+00:00","discovered_at":"2026-05-14T18:02:44.819128+00:00","generated_at":"2026-05-18T00:19:35.766271+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"InMed to present INM-901 preclinical data at AAIC 2025; long-term study shows multi-modal activity","bullets":["Preclinical data from INM-901 program presented at Alzheimer's Association International Conference (AAIC) 2025 in Toronto.","Long-term study in 5xFAD mouse model with advanced disease; treatment duration longer than previous studies.","INM-901 reduced inflammatory biomarkers IFN-γ, TNF-α, IL-1β, KC-GRO, IL-2, NfL in dose-dependent manner.","Immunohistochemistry showed dose-dependent reduction in amyloid-beta immunoreactivity and partial restoration of MAP2.","Behavioral improvements: cognitive function, anxiety-related behavior, sensory responsiveness restored or approaching normal."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-25-068190","json":"https://secwatch.observer/filing/0001213900-25-068190.json","markdown":"https://secwatch.observer/filing/0001213900-25-068190.md","text":"https://secwatch.observer/filing/0001213900-25-068190.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1728328/000121390025068190/0001213900-25-068190-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1728328/000121390025068190/ea0250489-8k_inmed.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-18T00:19:35.766271+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}